advanced search

Welcome: Guest

log in

Global Pharmaceutical Fine Chemicals

Industry and market analysis

Publication Date July 2004
Publisher URCH Publishing
Product Type Report
Pages 170
ISBN Number 954698142
Product Code URC00007
Price

£925.00
approximately: $1,597 | €1,174

PDF immediate deliveryBuy Now
PRINT £895 ($1,545 | €1,136)Buy Now
Order above formats by FAXOrder by FAX

Summary

Global Pharmaceutical Fine Chemicals - Industry and Market Analysis, examines the development of the industry and outlines the issues that are shaping the industry of tomorrow. The 170 page report explains how fine chemicals companies serve the various sub-sectors of the pharmaceutical industry and what factors will affect the industry. This unique document will give you and your organisation the knowledge of how pharmaceutical fine chemicals are manufactured and sold, as well as deepening understanding of the crucial role that PFC producers play in the supply of medical chemicals to the global drug industry.

The publication contains extensive profiles of leading companies including

- BASF AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation, Central and Eastern Europe, China, Cipla Limited, Clariant, Degussa AG, DSM Fine Chemicals, Eastman Fine Chemicals, Kaneka, Krka D.D, Lonza Group Ltd, Merck & Company, Inc., North China Pharmaceutical Group Corporation, Pliva D.D., Ranbaxy Laboratories Limited, Roche Group, Sankyo Company, Limited, Shijiazhuang Pharmaceutical Group Co., Ltd, Sigma-Aldrich, Takeda Chemical Industries and The Rhodia Group Ltd.

Content

  • 1. BACKGROUND AND HISTORY OF PFC INDUSTRY
  • 2. DEMAND FOR PFC
    • 3. SUPPLY OF PFC CHEMICALS
    • 4. TECHNOLOGIES IN PFC
    • 5. OVERVIEW OF PFC BUSINESS
    • 6. TYPES OF CUSTOMERS FOR PFC
    • 7. PFC COMPANY TYPES AND REGIONAL ANALYSIS
    • 8. PROFILES OF PFC PRODUCING COMPANIES
    • 9. PROFILES OF REGIONAL PHARMACEUTICAL COMPANIES
    • 10. CURRENT STATE OF THE PFC INDUSTRY
    • 11. OUTLOOK FOR GLOBAL PFC INDUSTRY
    • 12. MERGERS AND ACQUISITIONS